Kumar P. Chandra
Agra, UP, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A Prospective Real-world Study to Assess Safety, Tolerability, and Effectiveness of Imeglimin among People with Type 2 Diabetes Mellitus Who are Intolerant to Metformin (PRISM Study).
Journal: The Journal of the Association of Physicians of India
Published: March 12, 2026
Real-World Evidence of Tirzepatide in Indian Adults With Type 2 Diabetes: Significant Early Glycemic and Cardiometabolic Benefits.
Journal: Cureus
Published: February 02, 2026
A multicentre survey of liver fibrosis burden in type 2 diabetes in India: the DiaFib-Liver Study.
Journal: The Lancet regional health. Southeast Asia
Published: September 28, 2025
Effectiveness of Saroglitazar in MASLD Patients: A Prospective, Real-World Assessment of Liver and Metabolic Health.
Journal: Endocrinology, diabetes & metabolism
Published: August 18, 2025
Inappropriate Use of Serum Osmolarity Formulas in the Measurement of Urine Osmolality.
Journal: Indian journal of endocrinology and metabolism
Published: September 09, 2024
Our Experiences and Learnings in Diagnosing MODY from Non-Institutional-Based Diabetes Care Clinics.
Our Experiences and Learnings in Diagnosing MODY from Non-Institutional-Based Diabetes Care Clinics.
Journal: Indian journal of endocrinology and metabolism
Published: September 06, 2023
Screening of Individuals with Type 2 Diabetes on Anti-Diabetic Agents for Probable Hypoglycaemia Using the Stanford Hypoglycemia Questionnaire (SHQ) in Outpatient Settings: A Cross-Sectional Study from Outpatient Diabetes Care Centres in North India.
Journal: Indian journal of endocrinology and metabolism
Published: January 27, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026